Journal profile · RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Imagerie de la Femme
ISSN 1776-9817 · eISSN 2214-8485 · Elsevier
Imagerie de la Femme: CAS Zone 4 · Medicine (2025 upgraded edition); hybrid open access; APC about USD 1,770; review about 33 days (submission to acceptance, publisher); 43 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Imagerie de la Femme is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Breast Lesions and Carcinomas, Breast Cancer Treatment Studies and MRI in cancer diagnosis, together about 27.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Un contenu d'enseignement post-universitaire Imagerie de la Femme propose de nombreuses rubriques pratiques : Mises au point, Cas cliniques commentés, Passerelles cliniques, Corrélations anatomo-radiologiques, Quel est votre diagnostic, Analyse bibliographique commentée, Actualités techniques, Agenda. Une approche pluridisciplinaire La revue se consacre aux différents aspects de l'imagerie de la femme, que ce soit pour la partie radiologique traditionnellement la plus développée, la sénologie, ou la gynécologie, l'obstétrique et les autres explorations de la ménopause, telle que l'ostéodensitométrie. Une iconographie en couleurs Imagerie de la Femme propose une iconographie riche et en couleurs pour une lecture plus fine, moderne et dynamique.
From the journal's Aims & Scope
Research area (LetPub): RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Editor-in-chief Benoît MesurollePublisher website
Editorial board by country: none in mainland China; most named France 15, Canada 4, Switzerland 2 (21 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Breast Lesions and CarcinomasMedicine12.1%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology9.8%
- MRI in cancer diagnosisMedicine5.7%
- Ovarian cancer diagnosis and treatmentMedicine5.5%
- Endometriosis Research and TreatmentMedicine5.5%
- Cancer and Skin LesionsMedicine4.9%
- Uterine Myomas and TreatmentsMedicine4.9%
- Radiomics and Machine Learning in Medical ImagingMedicine4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.1LetPub ·
- CiteScore (publisher)
- 0.1Publisher website ·
- SJR 2026-06
- 0.1LetPub ·
- SNIP 2026-06
- 0.01LetPub ·
- h-index
- 8OpenAlex ·
- i10-index
- 5OpenAlex ·
- 2-year mean citedness
- 0.07OpenAlex ·
- Share of gold OA articles
- 12.64%LetPub ·
Volume
- Articles per year
- 29LetPub ·
Articles by year OpenAlex count · 1,085 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 20 | 2 | 1 |
| 2025 | 43 | 7 | 4 |
| 2024 | 41 | 20 | 2 |
| 2023 | 55 | 23 | 7 |
| 2022 | 23 | 10 | 11 |
| 2021 | 32 | 9 | 21 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
33 dayssubmission to acceptance
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Submission to first decision
- 32 daysPublisher website ·
- First decision after review
- 108 daysPublisher website ·
- Submission to acceptance
- 33 daysPublisher website ·
- Acceptance to publication
- 66 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 1,770 / EUR 1,610 / GBP 1,420 / JPY 219,530 | — | — | |
| Publisher website | USD 1,770 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteConflicts of interest, Open access
- Conflicts of interest
Co-submission of related data, methods or protocols to Data in Brief or MethodsX is encouraged. Model summary
You are encouraged to publish a description of your research data, methods, or protocols related to your regular article as a co-submission article in Data in Brief or MethodsX.
Source ↗Publisher website ·- Open access Open Access
Article Publishing Charge (APC): USD 1,770 (excluding taxes). The amount you pay may be reduced during submission if applicable.Review this journal’s open access policy.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 1776-9817
- Electronic ISSN
- 2214-8485
- Society / sponsor
- Société d'imagerie de la femme
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Imagerie de la Femme
What CAS zone is Imagerie de la Femme in?
In the 2025 upgraded edition of the CAS Journal Ranking, Imagerie de la Femme is in Zone 4 of Medicine, and in Zone 4 of the minor category Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Imagerie de la Femme?
The publisher reports about 33 days (submission to acceptance). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Imagerie de la Femme based?
Of the 21 board members whose country the journal's board page names, none are in mainland China; the countries named most often are France (15), Canada (4) and Switzerland (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Imagerie de la Femme?
According to LetPub and DOAJ records, Imagerie de la Femme is indexed in ESCI and Scopus.
Is Imagerie de la Femme open access, and what is the APC?
Imagerie de la Femme is a hybrid journal. For open-access publication: APC about USD 1,770.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .